PortfoliosLab logoPortfoliosLab logo
XBIT vs. IBIO
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

XBIT vs. IBIO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in XBiotech Inc. (XBIT) and iBio, Inc. (IBIO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

Over the past 10 years, XBIT has outperformed IBIO with an annualized return of -16.62%, while IBIO has yielded a comparatively lower -52.43% annualized return.


XBIT

1D
-0.84%
1M
-7.06%
YTD
-0.84%
6M
-5.58%
1Y
-19.39%
3Y*
-24.92%
5Y*
-30.49%
10Y*
-16.62%

IBIO

1D
4.89%
1M
19.88%
YTD
0.00%
6M
50.78%
1Y
95.28%
3Y*
-49.53%
5Y*
-69.23%
10Y*
-52.43%
*Multi-year figures are annualized to reflect compound growth (CAGR)

XBIT vs. IBIO - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
XBIT
XBiotech Inc.
-0.84%-39.49%-1.25%13.96%-68.46%-17.46%-16.15%267.42%28.93%-61.07%
IBIO
iBio, Inc.
0.00%-21.22%78.83%-84.59%-96.76%-47.71%320.00%-66.82%-58.14%-54.43%

Correlation

The correlation between XBIT and IBIO is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.07

Correlation (3Y)
Calculated over the trailing 3-year period

0.10

Correlation (5Y)
Calculated over the trailing 5-year period

0.15

Correlation (10Y)
Calculated over the trailing 10-year period

0.10

Correlation (All Time)
Calculated using the full available price history since Apr 16, 2015

0.09

Fundamentals

Market Cap

XBIT:

$72.26M

IBIO:

$230.83M

EPS

XBIT:

-$1.32

IBIO:

-$0.38

PB Ratio

XBIT:

0.54

IBIO:

2.98

Total Revenue (TTM)

XBIT:

$0.00

IBIO:

$300.00K

Gross Profit (TTM)

XBIT:

-$805.00K

IBIO:

-$230.00K

EBITDA (TTM)

XBIT:

-$42.42M

IBIO:

-$16.93M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

XBIT vs. IBIO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

XBIT
XBIT Risk / Return Rank: 2525
Overall Rank
XBIT Sharpe Ratio Rank: 2525
Sharpe Ratio Rank
XBIT Sortino Ratio Rank: 2525
Sortino Ratio Rank
XBIT Omega Ratio Rank: 2525
Omega Ratio Rank
XBIT Calmar Ratio Rank: 2424
Calmar Ratio Rank
XBIT Martin Ratio Rank: 2828
Martin Ratio Rank

IBIO
IBIO Risk / Return Rank: 7171
Overall Rank
IBIO Sharpe Ratio Rank: 6767
Sharpe Ratio Rank
IBIO Sortino Ratio Rank: 7676
Sortino Ratio Rank
IBIO Omega Ratio Rank: 7171
Omega Ratio Rank
IBIO Calmar Ratio Rank: 7272
Calmar Ratio Rank
IBIO Martin Ratio Rank: 6868
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

XBIT vs. IBIO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for XBiotech Inc. (XBIT) and iBio, Inc. (IBIO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


XBITIBIODifference
Sharpe ratioReturn per unit of total volatility

-1.20

Sortino ratioReturn per unit of downside risk

-2.31

Omega ratioGain probability vs. loss probability

0.97

1.23

-0.26

Calmar ratioReturn relative to maximum drawdown

-0.49

1.78

-2.28

Martin ratioReturn relative to average drawdown

-0.75

3.38

-4.13

XBIT vs. IBIO - Sharpe Ratio Comparison

The current XBIT Sharpe Ratio is -0.38, which is lower than the IBIO Sharpe Ratio of 0.82. The chart below compares the historical Sharpe Ratios of XBIT and IBIO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


XBITIBIODifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.38

0.82

-1.20

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.48

-0.45

-0.03

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.22

-0.33

+0.11

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.23

-0.23

0.00

Drawdowns

XBIT vs. IBIO - Drawdown Comparison

The maximum XBIT drawdown since its inception was -92.67%, smaller than the maximum IBIO drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for XBIT and IBIO.


Loading charts...

Drawdown Indicators


XBITIBIODifference

Max Drawdown

Largest peak-to-trough decline

-92.67%

-100.00%

+7.33%

Max Drawdown (1Y)

Largest decline over 1 year

-39.43%

-53.75%

+14.32%

Max Drawdown (3Y)

Largest decline over 3 years

-78.56%

-96.51%

+17.95%

Max Drawdown (5Y)

Largest decline over 5 years

-87.21%

-99.93%

+12.72%

Max Drawdown (10Y)

Largest decline over 10 years

-90.72%

-99.98%

+9.26%

Current Drawdown

Current decline from peak

-91.27%

-99.99%

+8.72%

Average Drawdown

Average peak-to-trough decline

-70.11%

-86.67%

+16.56%

Ulcer Index

Depth and duration of drawdowns from previous peaks

25.92%

28.29%

-2.37%

Volatility

XBIT vs. IBIO - Volatility Comparison

The current volatility for XBiotech Inc. (XBIT) is 6.88%, while iBio, Inc. (IBIO) has a volatility of 26.14%. This indicates that XBIT experiences smaller price fluctuations and is considered to be less risky than IBIO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


XBITIBIODifference

Volatility (1M)

Calculated over the trailing 1-month period

6.88%

26.14%

-19.26%

Volatility (6M)

Calculated over the trailing 6-month period

27.26%

87.98%

-60.72%

Volatility (1Y)

Calculated over the trailing 1-year period

51.89%

117.98%

-66.09%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

64.04%

153.42%

-89.38%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

75.31%

156.96%

-81.65%

Dividends

XBIT vs. IBIO - Dividend Comparison

Neither XBIT nor IBIO has paid dividends to shareholders.


PositionTTM20252024202320222021
IBIO
iBio, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%
XBIT
XBiotech Inc.
0.00%0.00%0.00%0.00%0.00%22.46%

Financials

XBIT vs. IBIO - Financials Comparison

This section allows you to compare key financial metrics between XBiotech Inc. and iBio, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00M2.00M3.00M4.00M5.00M2022202320242025202600
(XBIT) Total Revenue
(IBIO) Total Revenue
Values in USD except per share items

Frequently Asked Questions


XBIT and IBIO have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

IBIO has higher volatility (26.14%) compared to XBIT (6.88%). In terms of maximum drawdown, XBIT dropped -92.67% vs IBIO's -100.00%.

IBIO currently has the higher Sharpe Ratio (0.82 vs -0.38), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for XBIT and IBIO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer